Bone Return On Assets from 2010 to 2024

BBLGW Stock  USD 28.49  3.29  10.35%   
Bone Biologics Return On Assets yearly trend continues to be fairly stable with very little volatility. Return On Assets will likely drop to -2.51 in 2024. Return On Assets is a profitability ratio that indicates the percentage of profit Bone Biologics Corp earns in relation to its overall resources. It is calculated by dividing net income by total assets. View All Fundamentals
 
Return On Assets  
First Reported
2010-12-31
Previous Quarter
(2.39)
Current Value
(2.51)
Quarterly Volatility
105.30740638
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bone Biologics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bone Biologics' main balance sheet or income statement drivers, such as Other Operating Expenses of 9.9 M, Ebitda of 503.6 K or Total Operating Expenses of 4.7 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.43. Bone financial statements analysis is a perfect complement when working with Bone Biologics Valuation or Volatility modules.
  
Check out the analysis of Bone Biologics Correlation against competitors.

Latest Bone Biologics' Return On Assets Growth Pattern

Below is the plot of the Return On Assets of Bone Biologics Corp over the last few years. It is a profitability ratio that indicates the percentage of profit a company earns in relation to its overall resources. It is calculated by dividing net income by total assets. Bone Biologics' Return On Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bone Biologics' overall financial position and show how it may be relating to other accounts over time.
Return On Assets10 Years Trend
Slightly volatile
   Return On Assets   
       Timeline  

Bone Return On Assets Regression Statistics

Arithmetic Mean(51.76)
Geometric Mean4.95
Coefficient Of Variation(203.46)
Mean Deviation74.62
Median(4.26)
Standard Deviation105.31
Sample Variance11,090
Range302
R-Value0.57
Mean Square Error8,037
R-Squared0.33
Significance0.03
Slope13.47
Total Sum of Squares155,255

Bone Return On Assets History

2024 -2.51
2023 -2.39
2022 0.0819
2020 -0.24
2019 -111.1
2018 -4.26
2017 -8.86

About Bone Biologics Financial Statements

Bone Biologics investors use historical fundamental indicators, such as Bone Biologics' Return On Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Bone Biologics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Return On Assets(2.39)(2.51)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Bone Stock Analysis

When running Bone Biologics' price analysis, check to measure Bone Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bone Biologics is operating at the current time. Most of Bone Biologics' value examination focuses on studying past and present price action to predict the probability of Bone Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bone Biologics' price. Additionally, you may evaluate how the addition of Bone Biologics to your portfolios can decrease your overall portfolio volatility.